| dc.creator | Olivares R., Gabriel | |
| dc.creator | Veas, Nicolás | |
| dc.date.accessioned | 2022-04-12T21:43:22Z | |
| dc.date.accessioned | 2022-10-17T16:46:08Z | |
| dc.date.available | 2022-04-12T21:43:22Z | |
| dc.date.available | 2022-10-17T16:46:08Z | |
| dc.date.created | 2022-04-12T21:43:22Z | |
| dc.date.issued | 2021 | |
| dc.identifier | Rev. Med. Chile 2021; 149: 1182-1188 | |
| dc.identifier | 0034-9887 | |
| dc.identifier | https://repositorio.uchile.cl/handle/2250/184880 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4421132 | |
| dc.description.abstract | Recent randomized controlled trials confirmed the beneficial outcomes with
coronary artery bypass grafting (CABG) compared with percutaneous coronary
intervention (PCI) in patients with severe three-vessel coronary artery and left
main disease. An increased long-term survival after CABG is associated with a
reduction in spontaneous myocardial infarction and repeat revascularization rates.
While PCI treats only flow-limiting lesions, CABG treats the whole coronary
artery, preventing events in the future. Due to different clinical and anatomic
factors affecting the outcomes, the heart team should formulate treatment assignment
recommendations. | |
| dc.language | es | |
| dc.publisher | Soc Medica Santiago | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
| dc.source | Revista Médica de Chile | |
| dc.subject | Cardiovascular surgical procedures | |
| dc.subject | Coronary artery disease | |
| dc.subject | Percutaneous coronary intervention | |
| dc.title | Cirugía de revascularización miocárdica versus angioplastía en el tratamiento de la enfermedad coronaria de tres vasos y tronco de la coronaria izquierda | |
| dc.type | Artículos de revistas | |
